DrugCite
Search

ACZ

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Acz Adverse Events Reported to the FDA Over Time

How are Acz adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Acz, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Acz is flagged as the suspect drug causing the adverse event.

Most Common Acz Adverse Events Reported to the FDA

What are the most common Acz adverse events reported to the FDA?

Pyrexia
83 (5.31%)
Cough
37 (2.37%)
Pneumonia
29 (1.86%)
Thrombocytopenia
28 (1.79%)
Dyspnoea
27 (1.73%)
Histiocytosis Haematophagic
25 (1.6%)
Inflammation
22 (1.41%)
Malaise
22 (1.41%)
Abdominal Pain
21 (1.34%)
Vomiting
20 (1.28%)
Anaemia
19 (1.22%)
Show More Show More
Lymphadenopathy
19 (1.22%)
Pleural Effusion
19 (1.22%)
Erythema
17 (1.09%)
Headache
16 (1.02%)
Leukopenia
16 (1.02%)
Disease Progression
15 (.96%)
Nausea
15 (.96%)
Rhinorrhoea
15 (.96%)
Lung Infiltration
14 (.9%)
Pancytopenia
14 (.9%)
C-reactive Protein Increased
13 (.83%)
Viral Infection
13 (.83%)
Mechanical Ventilation
12 (.77%)
Chronic Obstructive Pulmonary Disea...
11 (.7%)
Decreased Appetite
11 (.7%)
Epstein-barr Virus Infection
11 (.7%)
Hypotension
11 (.7%)
Convulsion
10 (.64%)
Disorientation
10 (.64%)
Leukocytosis
10 (.64%)
Lymphocyte Morphology Abnormal
10 (.64%)
Platelet Count Decreased
10 (.64%)
Pulmonary Hypertension
10 (.64%)
Renal Failure
10 (.64%)
Tachypnoea
10 (.64%)
Urticaria
10 (.64%)
Arthralgia
9 (.58%)
Breath Sounds Abnormal
9 (.58%)
Bronchitis
9 (.58%)
Computerised Tomogram Abnormal
9 (.58%)
Concomitant Disease Progression
9 (.58%)
Fibrin D Dimer Increased
9 (.58%)
Hepatomegaly
9 (.58%)
Myalgia
9 (.58%)
Pain
9 (.58%)
Splenomegaly
9 (.58%)
Venoocclusive Disease
9 (.58%)
Atelectasis
8 (.51%)
Ear Pain
8 (.51%)
Hepatosplenomegaly
8 (.51%)
Meningitis Mumps
8 (.51%)
Nuchal Rigidity
8 (.51%)
Parotid Gland Enlargement
8 (.51%)
Productive Cough
8 (.51%)
Sinus Tachycardia
8 (.51%)
White Blood Cell Count Decreased
8 (.51%)
Abnormal Behaviour
7 (.45%)
Ascites
7 (.45%)
Pruritus
7 (.45%)
Thoracic Cavity Drainage
7 (.45%)
Upper Respiratory Tract Infection
7 (.45%)
Urinary Tract Infection
7 (.45%)
Amyloidosis
6 (.38%)
Cardiac Arrest
6 (.38%)
Cardiac Tamponade
6 (.38%)
Chest Pain
6 (.38%)
Granuloma
6 (.38%)
Haemophilus Infection
6 (.38%)
Haptoglobin Decreased
6 (.38%)
Interstitial Lung Disease
6 (.38%)
Joint Swelling
6 (.38%)
Nephrectomy
6 (.38%)
Oedema Peripheral
6 (.38%)
Pericarditis Tuberculous
6 (.38%)
Peritoneal Tuberculosis
6 (.38%)
Pleurisy
6 (.38%)
Pulmonary Oedema
6 (.38%)
Pulmonary Tuberculosis
6 (.38%)
Rales
6 (.38%)
Respiratory Failure
6 (.38%)
Sepsis
6 (.38%)
Serositis
6 (.38%)
Serum Ferritin Increased
6 (.38%)
Somnolence
6 (.38%)
Tumour Necrosis Factor Receptor-ass...
6 (.38%)
Alanine Aminotransferase Abnormal
5 (.32%)
Aspartate Aminotransferase Abnormal
5 (.32%)
Bronchopneumonia
5 (.32%)
Depressed Level Of Consciousness
5 (.32%)
Ear Infection
5 (.32%)
Haematuria
5 (.32%)
Heart Rate Decreased
5 (.32%)
Hypoxia
5 (.32%)
Liver Function Test Abnormal
5 (.32%)
Lung Consolidation
5 (.32%)
Mediastinal Shift
5 (.32%)
Micturition Frequency Decreased
5 (.32%)
Neutropenia
5 (.32%)
Oropharyngeal Pain
5 (.32%)
Rash Maculo-papular
5 (.32%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Acz, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Acz is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Acz

What are the most common Acz adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Acz, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Acz is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Acz According to Those Reporting Adverse Events

Why are people taking Acz, according to those reporting adverse events to the FDA?

Juvenile Arthritis
35
Gout
30
Cryopyrin Associated Periodic Syndr...
24
Rheumatoid Arthritis
13
Chronic Infantile Neurological Cuta...
10
Chronic Obstructive Pulmonary Disea...
8
Show More Show More
Muckle-wells Syndrome
6
Tumour Necrosis Factor Receptor-ass...
4
Type 2 Diabetes Mellitus
3
Blood Immunoglobulin D Increased
1
Pyrexia
1
Diabetes Mellitus
1
Familial Cold Autoinflammatory Synd...
1

Acz Case Reports

What Acz safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Acz. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Acz.